Assessment of Suspected Malignancy or Infection in Immunocompromised Patients After Solid Organ Transplantation by [18F]FDG PET/CT and [18F]FDG PET/MRI-Reference-Cited by-同舟云学术

Assessment of Suspected Malignancy or Infection in Immunocompromised Patients After Solid Organ Transplantation by [18F]FDG PET/CT and [18F]FDG PET/MRI

Published:2020-07-02 Issue:4 Volume:54 Page:183-191
ISSN:1869-3474
Container-title:Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Nucl Med Mol Imaging

Author:

Guberina Nika,Gäckler Anja,Grueneisen Johannes,Wetter Axel,Witzke Oliver,Herrmann Ken,Rischpler Christoph,Fendler Wolfgang,Umutlu Lale,Sawicki Lino Morris,Forsting Michael,Rohn Hana

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging

Link

https://link.springer.com/content/pdf/10.1007/s13139-020-00648-5.pdf

Reference25 articles.

1. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med. 2000;342:605–12.

2. Engels EA, Pfeiffer RM, Fraumeni JF Jr, Kasiske BL, Israni AK, Snyder JJ, et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA. 2011;306:1891–901.

3. Pizzo PA. Fever in immunocompromised patients. N Engl J Med. 1999;341:893–900.

4. Fishman JA. Infection in organ transplantation. Am J Transplant. 2017;17:856–79.

5. Vajdic CM, van Leeuwen MT. Cancer incidence and risk factors after solid organ transplantation. Int J Cancer. 2009;125:1747–54.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. [18F]FDG PET/CT Findings of Mass-Forming Actinomycosis in an Uncontrolled Diabetic Patient;Nuclear Medicine and Molecular Imaging;2023-07-13

2. The progress of PET/MRI in clinical management of patients with pancreatic malignant lesions;Frontiers in Oncology;2023-04-28

3. The Possibilities of Nuclear Medicine Methods in Inflammation Diagnosis;Journal of oncology: diagnostic radiology and radiotherapy;2022-06-25

4. FDG-PET/CT in Heart Transplant;FDG-PET/CT and PET/MR in Cardiovascular Diseases;2022

5. 18F-FDG PET/CT for Evaluation of Post-Transplant Lymphoproliferative Disorder (PTLD);Seminars in Nuclear Medicine;2021-07